THOR’s consolidated results were primarily driven by the results of its individual reportable segments as noted below. North American Towable RV net sales were down 4.9% for the first quarter of ...
The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...